Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06QRW
|
||||
Former ID |
DIB003873
|
||||
Drug Name |
Lazabemide
|
||||
Synonyms |
Lazabemine; Pakio; Tempium; Ro-19-6327; Ro-41-3776; Ro-19-6327/000
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Roche Holding AG
|
||||
Structure |
Download2D MOL |
||||
Formula |
C8H10ClN3O
|
||||
InChI |
InChI=1S/C8H10ClN3O/c9-6-1-2-7(12-5-6)8(13)11-4-3-10/h1-2,5H,3-4,10H2,(H,11,13)
|
||||
InChIKey |
JZXRLKWWVNUZRB-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
7980091, 8194561, 15220005, 43127665, 47206517, 50064090, 50112873, 50460487, 57318127, 92729659, 103183900, 103831836, 103938836, 104350168, 117465703, 126424309, 128351763, 132555187, 134343054, 135028045, 137239417, 139290484, 139640715, 164814824, 178103253, 179149503, 184545911, 198970494, 224982470, 226493370, 252216705, 252351209, 252428934
|
||||
Target and Pathway | |||||
Target(s) | Amine oxidase [flavin-containing] B | Target Info | Inhibitor | [534569] | |
KEGG Pathway | Glycine, serine and threonine metabolism | ||||
Arginine and proline metabolism | |||||
Histidine metabolism | |||||
Tyrosine metabolism | |||||
Phenylalanine metabolism | |||||
Tryptophan metabolism | |||||
Drug metabolism - cytochrome P450 | |||||
Metabolic pathways | |||||
Serotonergic synapse | |||||
Dopaminergic synapse | |||||
Cocaine addiction | |||||
Amphetamine addiction | |||||
Alcoholism | |||||
Pathway Interaction Database | Alpha-synuclein signaling | ||||
References | |||||
Ref 541750 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6640). | ||||
Ref 545650 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004032) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.